期刊文献+

肥胖和非肥胖高血压患者胰岛β细胞早期分泌相的改变 被引量:1

Changes of Earlyphase Insulin Secretion in Hypertensive Patients with or without Obesity
下载PDF
导出
摘要 目的了解肥胖高血压和非肥胖高血压患者胰岛β细胞早期分泌相的变化规律。方法用左旋精氨酸(L-Arg)刺激法对高血压患者胰岛β细胞分泌功能进行了研究。结果(1)空腹胰岛素(INS)、C肽值肥胖高血压组明显高于对照组和非肥胖高血压组(P<0.05或P<0.01),后两者间无明显差异(P>0.05)。(2)L-Arg兴奋后肥胖高血压和非肥胖高血压组INS和C肽分泌在4min时达峰值,而对照组2min达峰值。(3)L-Arg兴奋后INS和C肽各时间点增加值的和(ΔΣ)肥胖高血压组明显高于对照组和非肥胖高血压组,后两者无显著差异。(4)肥胖高血压组ΔΣINS与DBP和体重身高指数(BMI)均呈明显正相关(P<0.05),非肥胖高血压组则无相关性。结论肥胖高血压患者存在胰岛素抵抗,L-Arg刺激胰岛β细胞早期分泌相是增加的;非肥胖高血压患者胰岛素抵抗不明显。 Aim To explore the early plasma insulin secretion in hypertensive patients with and without obesity. Methods With view to defining the changes of early secretion function of islet βcells in hypertensive patients with or without obesity, Larginine(LArg) was used to stimulate insulin secretion of islet β cell. Results (1)The levels of fasting insulin(INS) and cpeptide in obese hypertensive group(OH) were clearly higher than those of control group(CG) and nonobese hypertensive group(NOH). There was no difference between the latter two groups. (2)The peak values of INS and Cpeptide in OH and NOH stimulated by LArg was found at the fourth minutes; while in the control group it occurred at the second minutes. The peak values of INS were highest in OH among the three groups. (3)The increases in INS and Cpeptide (ΔΣ) in NOH and control group were significantly smaller than that of OH patients, but there were no difference between NOH and control group. (4)Multiple regression analysis demonstrated that ΔΣ INS had positive correlation with diastolic pressure and body mass index, fasting INS also positive correlated with body mass index. Conclusion The firstphase insulin secretion responsed to LArg was increased in OH,the mechanism of which may be ascribed to the insulin resistance.
出处 《高血压杂志》 CSCD 1998年第1期36-38,共3页 Chinese Journal of Hypertension
关键词 高血压 胰岛Β细胞 肥胖 早期分泌相 hypertention insulin secretion
  • 相关文献

同被引文献36

  • 1陈达光,林金秀,曾开淇,郑舒亮,黄端,李宝彬.肥胖和高血压病患者胰岛素敏感性的变化[J].中华医学杂志,1996,76(7):519-523. 被引量:44
  • 2中岛忠久.肥胖和高血压[J].最新医学,1993,48(6):79-79.
  • 3Ferrannini E,Natali A,Bell P, et al. Insulin resistance and hypersecretion in obesity. Euroupean Group for the Study of insulin Resistanee (EG1R). J Clin Invest, 1997,100 : 1166-73.
  • 4Cohen PG. Aromatase, adiposity, aging, and disease. The hypogonadalmetabolic-atherogenic-disease and aging connection. Med Hypotheses, 2001,56 (6) : 702-708.
  • 5Boden G. Role of acids in the pathogenesis of insulin resistance and NIDDM. Diabetes, 1997,46 : 3.
  • 6Saghizadeh M. The expression of TNF-a by human muscle: relation to insulin fesistance. J clin invest, 1997,97:1111.
  • 7Straczkowski M,Lewezuk P, Dzienis-straezkowska S, et al. Elevated soluble intercellular zdhesion molecule-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity. Metabolism, 2002,51 (1): 75-78.
  • 8Thakur V, Richards R,Reisin E. Insulin resistance in hypertension is associated body fat rather than blood pressure. Am J Med Sci, 2001,321(4) : 242-248.
  • 9Markus C, stiihlinger, Fahim Abbasi,et al. Relationship between Insulin resistance and an Endogenous Nitric Oxide Synthase Inhibitor. JAMA, 2002,287 : 1420-1426.
  • 10Zhang YY, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature, 1994,372:425-431.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部